您的当前位置:首页 > 行业数据 > 图表6二代ALK针对克唑替尼耐药ORR对比
图片属性
图片格式:PNG 图片大小:54KB 图片尺寸:1149*767
同报告图片
 / 4
图表6二代ALK针对克唑替尼耐药ORR对比_第1页
fCDpobnnm64gICB8IOaVsOaNriAgfAp8LS0tLS0tLS18LS0tLS0tLXwKfCBTWS03MDcgfCA1MiUgICB8Cnwg6Zi/5p2l5pu/5bC8IHwgNTElICAgfAp8IOWhnueRnuabv+WwvCB8IDQ0JSAgIHwKfCDmganmspnmm7/lsLwgfCA1MiUgICB8CgrotYTmlpnmnaXmupDvvJrlkITlhazlj7jlrpjnvZHvvIzljY7liJvor4HliLg=
图表6二代ALK针对克唑替尼耐药ORR对比_第2页
图表6二代ALK针对克唑替尼耐药ORR对比_第3页
fCDpobnnm64gICB8IOaVsOaNriAgfAp8LS0tLS0tLS18LS0tLS0tLXwKfCBTWS03MDcgfCA1MiUgICB8Cnwg6Zi/5p2l5pu/5bC8IHwgNTElICAgfAp8IOWhnueRnuabv+WwvCB8IDQ0JSAgIHwKfCDmganmspnmm7/lsLwgfCA1MiUgICB8CgrotYTmlpnmnaXmupDvvJrlkITlhazlj7jlrpjnvZHvvIzljY7liJvor4HliLg=
图表6二代ALK针对克唑替尼耐药ORR对比_第4页
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
图表6二代ALK针对克唑替尼耐药ORR对比_第5页
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
所属报告: 首药控股-深度研究报告:小分子自主研发能力强大三代ALK有望同类最佳-221207(17页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠